BGLAP and chronic kidney disease: CKD rats treated with LP 30 had the lowest Bglap mRNA levels among all analyzed uremic groups, and a positive relationship existed between this gene’s expression and both TDO expression (Figure 7B) and KYN/TRP ratio in trabecular bone (Figure 7C) of uremic rats treated with LP533401.